Summary
The phenomenon of regression to the mean is widespread. It may affect any quantitative biological data in which there is “within subject” variability. It is demonstrated, as an example in practice, by a shift from high to lower values with time in a selected subset of patients with an abnormally high blood cholesterol. The phenomenon will influence experiments involving before-after measurements of a continuous variable. An incorrect conclusion may be reached if investigators do not take regression to the mean into account when designing a clinical trial of hypolipidemic therapy. The reality of the phenomenon is illustrated by a prospective study.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Snedecor, G. W., Cochran, W. G.: Statistical Methods, Sixth Ed., p. 196. Ames: Iowa State University Press 1967
James, K. E.: Regression toward the mean in uncontrolled clinical studies. Biometrics29, 121–130 (1973)
Detre, K. M., Shaw, L. A. M.: Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease; Veterans Administration Drug-Lipid Cooperative Study. Circulation50, 998–1005 (1974)
Glasunov, I., Dowd, J., Jaksic, Z., Kesic, B., Ray, D., Steinberg, C., Stromberg, J., Vuletic, S.: Methodological aspects of the design and conduct of preventive trials in ischaemic heart disease. Int. J. Epidemiol.,2, 137–143 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boissel, J.P., Duperat, B. & Leizorovicz, A. The phenomenon of regression to the mean and clinical investigation of blood cholesterol lowering drugs. Eur J Clin Pharmacol 17, 227–230 (1980). https://doi.org/10.1007/BF00561905
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00561905